West Pharmaceutical Services Inc. (WST): Price and Financial Metrics

West Pharmaceutical Services Inc. (WST): $298.79

-1.93 (-0.64%)

POWR Rating

Component Grades














  • WST scores best on the Sentiment dimension, with a Sentiment rank ahead of 87.04% of US stocks.
  • WST's strongest trending metric is Stability; it's been moving down over the last 179 days.
  • WST's current lowest rank is in the Momentum metric (where it is better than 5.5% of US stocks).

WST Stock Summary

  • West Pharmaceutical Services Inc's market capitalization of $30,761,491,637 is ahead of 90.98% of US-listed equities.
  • WST's went public 34.25 years ago, making it older than 89.32% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for WST is currently 52.67, higher than 90.49% of US stocks with positive operating cash flow.
  • If you're looking for stocks that are quantitatively similar to West Pharmaceutical Services Inc, a group of peers worth examining would be SIRI, BCPC, SSTK, ICUI, and ALGN.
  • WST's SEC filings can be seen here. And to visit West Pharmaceutical Services Inc's official web site, go to www.westpharma.com.

WST Valuation Summary

  • In comparison to the median Healthcare stock, WST's price/sales ratio is 16.3% higher, now standing at 13.2.
  • WST's price/earnings ratio has moved NA NA over the prior 243 months.
  • Over the past 243 months, WST's price/earnings ratio has gone NA NA.

Below are key valuation metrics over time for WST.

Stock Date P/S P/B P/E EV/EBIT
WST 2021-08-31 13.2 16.4 64.3 52.6
WST 2021-08-30 13.2 16.4 64.4 52.7
WST 2021-08-27 13.1 16.3 63.7 52.1
WST 2021-08-26 13.1 16.3 63.6 52.1
WST 2021-08-25 13.0 16.2 63.3 51.8
WST 2021-08-24 13.1 16.2 63.5 52.0

WST Growth Metrics

    The 4 year cash and equivalents growth rate now stands at 88.27%.
  • Its 3 year price growth rate is now at 71.1%.
  • The 4 year price growth rate now stands at 177.8%.
WST's revenue has moved up $1,086,400,000 over the prior 34 months.

The table below shows WST's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 2,831.6 584 661.8
2021-09-30 2,681 571.9 612.5
2021-06-30 2,522.5 500.4 519.2
2021-03-31 2,326.1 504.1 423.1
2020-12-31 2,146.9 472.5 346.2
2020-09-30 2,037.3 430.2 311.7

WST's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • WST has a Quality Grade of B, ranking ahead of 77.04% of graded US stocks.
  • WST's asset turnover comes in at 0.924 -- ranking 9th of 22 Rubber and Plastic Products stocks.
  • TUP, MYE, and ENTG are the stocks whose asset turnover ratios are most correlated with WST.

The table below shows WST's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.924 0.405 0.359
2021-06-30 0.913 0.394 0.328
2021-03-31 0.885 0.375 0.281
2020-12-31 0.857 0.358 0.238
2020-09-30 0.852 0.348 0.220
2020-06-30 0.850 0.341 0.206

WST Price Target

For more insight on analysts targets of WST, see our WST price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $436.00 Average Broker Recommendation 1.5 (Moderate Buy)

WST Stock Price Chart Interactive Chart >

Price chart for WST

WST Price/Volume Stats

Current price $298.79 52-week high $475.35
Prev. close $300.72 52-week low $288.12
Day low $296.06 Volume 381,400
Day high $303.79 Avg. volume 443,329
50-day MA $357.48 Dividend yield 0.24%
200-day MA $404.43 Market Cap 22.13B

West Pharmaceutical Services Inc. (WST) Company Bio

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. (Source:Wikipedia)

WST Latest News Stream

Event/Time News Detail
Loading, please wait...

WST Latest Social Stream

Loading social stream, please wait...

View Full WST Social Stream

Latest WST News From Around the Web

Below are the latest news stories about West Pharmaceutical Services Inc that investors may wish to consider to help them evaluate WST as an investment opportunity.

Thermo Fisher (TMO) COVID Test Sales Grow, FX Woes Persist

Thermo Fisher's (TMO) strong pandemic response stance enables it to accelerate its growth strategy, and bump up investments, which encourages it to raise the 2022 core organic growth guidance.

Yahoo | February 25, 2022

Ravikrishna Chebolu joins West Pharmaceutical as GM of India

Hyderabad: West Pharmaceutical Services, which operates in injectable drug administration segment, appointed Ravikrishna Chebolu as GM of its India operations. While Wests global headquarter is in Exton, Pennsylvania, United States, in India the company has its sales office in Hyderabad, servicing customers throughout India. With over 20 years of relevant commercial and general management experience []

Telangana Today | February 23, 2022

Abbott (ABT) COVID Testing Sales Surge, FX Headwind Stays

Abbott (ABT) registers strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

Yahoo | February 23, 2022

West Announces Second-Quarter 2022 Dividend

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the Company's Board of Directors has approved a second-quarter 2022 dividend of $0.18 per share. The dividend will be paid on May 4, 2022, to shareholders of record as of April 20, 2022.

Yahoo | February 23, 2022

Medtronic's (MDT) Cryoablation Catheters Get FDA Expanded Nod

Medtronic's (MDT) Cardiac Cryoablation is the only ablation catheter approved to treat pediatric AVNRT.

Yahoo | February 22, 2022

Read More 'WST' Stories Here

WST Price Returns

1-mo -10.11%
3-mo -22.65%
6-mo -31.85%
1-year -13.08%
3-year 159.12%
5-year 214.05%
YTD -36.23%
2021 65.88%
2020 89.05%
2019 54.13%
2018 -0.08%
2017 17.02%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7279 seconds.